Summary of Study ST000921

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000637. The data can be accessed directly via it's Project DOI: 10.21228/M8B96C This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST000921
Study TitleKarenia brevis allelopathy compromises the lipidome, membrane integrity, and photosynthetic efficiency of competitors
Study TypeUntargeted lipidomics
Study SummaryAllelopathy, or the release of compounds that inhibit competitors, is a form of interference competition that is common among bloom-forming phytoplankton. Allelopathy is hypothesized to play a role in bloom propagation and maintenance and is well established in the red tide dinoflagellate Karenia brevis. K. brevis typically suppresses competitor growth through unknown mechanisms over the course of many days. When we investigated the effects of allelopathy on the lipidomes of two competing phytoplankton, Asterionellopsis glacialis and Thalassiosira pseudonana using nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS)- based metabolomics, we found that the lipidomes of both species were significantly altered, however A. glacialis maintained a more robust response whereas T. pseudonana saw significant alterations in fatty acid synthesis, cell membrane integrity, and a decrease in photosynthetic efficiency. Membrane- associated lipids were significantly suppressed for T. pseudonana exposed to allelopathy to the point of permeabilizing the cell membrane of living cells. The dominant mechanisms of K. brevis allelopathy appear to target lipid biosynthesis affecting multiple physiological pathways suggesting that exuded compounds have the ability to significantly alter competitor physiology and give K. brevis a competitive edge over sensitive species.
Institute
Georgia Institute of Technology
DepartmentChemistry
LaboratoryFernández
Last NameHogan
First NameScott
Address901 Atlantic Drive, Atlanta, GA, 30332, USA
Emailsrjhogan@gatech.edu
Phone2156924657
Submit Date2018-01-19
Num Groups4
Total Subjects51
Raw Data AvailableNo
Raw Data File Type(s)raw(Waters)
Analysis Type DetailLC-MS
Release Date2018-08-27
Release Version1
Scott Hogan Scott Hogan
https://dx.doi.org/10.21228/M8B96C
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Factors:

Subject type: Plankton; Subject species: Thalassiosira pseudonana;Karenia brevis (Factor headings shown in green)

mb_sample_id local_sample_id Class
SA054646TpC6Control
SA054647TpC11Control
SA054648TpC4Control
SA054649TpC12Control
SA054650TpC9Control
SA054651TpC15Control
SA054652TpC3Control
SA054653AgC2Control
SA054654TpC2Control
SA054655TpC5Control
SA054656TpC10Control
SA054657TpC8Control
SA054658TpC13Control
SA054659TpC7Control
SA054660AgC3Control
SA054661AgC5Control
SA054662AgC1Control
SA054663AgC6Control
SA054664AgC11Control
SA054665AgC4Control
SA054666AgC8Control
SA054667AgC12Control
SA054668AgC7Control
SA054669AgC9Control
SA054670AgC15Control
SA054671AgC10Control
SA054672TpT4treatment
SA054673TpT3treatment
SA054674TpT6treatment
SA054675TpT15treatment
SA054676TpT11treatment
SA054677TpT7treatment
SA054678TpT8treatment
SA054679TpT13treatment
SA054680TpT10treatment
SA054681TpT2treatment
SA054682TpT9treatment
SA054683TpT5treatment
SA054684AgT1treatment
SA054685AgT7treatment
SA054686AgT10treatment
SA054687AgT8treatment
SA054688AgT15treatment
SA054689AgT2treatment
SA054690AgT9treatment
SA054691AgT5treatment
SA054692AgT3treatment
SA054693AgT4treatment
SA054694AgT6treatment
SA054695AgT12treatment
SA054696AgT11treatment
Showing results 1 to 51 of 51
  logo